288 related articles for article (PubMed ID: 11472825)
1. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
De Campos AM; Sánchez A; Alonso MJ
Int J Pharm; 2001 Aug; 224(1-2):159-68. PubMed ID: 11472825
[TBL] [Abstract][Full Text] [Related]
2. Chitosan based nanocarriers for indomethacin ocular delivery.
Badawi AA; El-Laithy HM; El Qidra RK; El Mofty H; El dally M
Arch Pharm Res; 2008 Aug; 31(8):1040-9. PubMed ID: 18787795
[TBL] [Abstract][Full Text] [Related]
3. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B.
Das S; Suresh PK
Nanomedicine; 2011 Apr; 7(2):242-7. PubMed ID: 20692375
[TBL] [Abstract][Full Text] [Related]
4. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A.
Calvo P; Sanchez A; Martinez J; Lopez MI; Calonge M; Pastor JC; Alonso MJ
Pharm Res; 1996 Feb; 13(2):311-5. PubMed ID: 8932455
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK
Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737
[TBL] [Abstract][Full Text] [Related]
6. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.
Acheampong AA; Shackleton M; Tang-Liu DD; Ding S; Stern ME; Decker R
Curr Eye Res; 1999 Feb; 18(2):91-103. PubMed ID: 10223652
[TBL] [Abstract][Full Text] [Related]
7. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
8. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L
Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499
[TBL] [Abstract][Full Text] [Related]
9. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
[TBL] [Abstract][Full Text] [Related]
10. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
11. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
12. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
[TBL] [Abstract][Full Text] [Related]
13. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D
Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821
[TBL] [Abstract][Full Text] [Related]
14. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
Zhou W; Wang Y; Jian J; Song S
Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
[TBL] [Abstract][Full Text] [Related]
16. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
Liu D; Li J; Cheng B; Wu Q; Pan H
Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726
[TBL] [Abstract][Full Text] [Related]
17. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
Weiss SL; Kramer WG
J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
[No Abstract] [Full Text] [Related]
18. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
Di Tommaso C; Valamanesh F; Miller F; Furrer P; Rodriguez-Aller M; Behar-Cohen F; Gurny R; Möller M
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2292-9. PubMed ID: 22427552
[TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh KH; Shinde UA
Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
[TBL] [Abstract][Full Text] [Related]
20. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
